Cargando…
Anhedonia in cocaine use disorder is associated with inflammatory gene expression
Treatments for Cocaine Use Disorder (CUD) are variably effective, and there are no FDA-approved medications. One approach to developing new treatments for CUD may be to investigate and target poor prognostic signs. One such sign is anhedonia (i.e. a loss of pleasure or interest in non-drug rewards),...
Autores principales: | Fries, Gabriel Rodrigo, Khan, Sarwar, Stamatovich, Sydney, Dyukova, Elena, Walss-Bass, Consuelo, Lane, Scott D., Schmitz, Joy M., Wardle, Margaret C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224118/ https://www.ncbi.nlm.nih.gov/pubmed/30408130 http://dx.doi.org/10.1371/journal.pone.0207231 |
Ejemplares similares
-
45698 Molecular Signatures of Cocaine Neurotoxicity in Human Brain Models
por: Mendez, Emily, et al.
Publicado: (2021) -
4141 Molecular Signatures of Cocaine Toxicity in Postmortem Human Brain and Neurons
por: Mendez, Emily Frances, et al.
Publicado: (2020) -
Measures of possible allostatic load in comorbid cocaine and alcohol use disorder: Brain white matter integrity, telomere length, and anti-saccade performance
por: Tannous, Jonika, et al.
Publicado: (2019) -
White matter deficits in cocaine use disorder: convergent evidence from in vivo diffusion tensor imaging and ex vivo proteomic analysis
por: Tondo, Lucca Pizzato, et al.
Publicado: (2021) -
Estimating the direct effects of the genetic liabilities to bipolar disorder, schizophrenia, and behavioral traits on suicide attempt using a multivariable Mendelian randomization approach
por: Cabrera-Mendoza, Brenda, et al.
Publicado: (2023)